Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03570619
Title Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations (IMPACT)
Acronym IMPACT
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Michigan Rogel Cancer Center
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST